From a lipid specialist’s perspective, do the results from the ODYSSEY Outcomes Trial suggest the need to be more focused on achieving absolute target levels of LDL-C or relative percentage reductions in LDL-C levels?

From a lipid specialist’s perspective, do the results from the ODYSSEY Outcomes Trial suggest the need to be more focused on achieving absolute target levels of LDL-C or relative percentage reductions in LDL-C levels?

From a lipid specialist’s perspective, do the results from the ODYSSEY Outcomes Trial suggest the need to be more focused on achieving absolute target levels of LDL-C or relative percentage reductions in LDL-C levels?


Created by

CMEducation Resources IQ&A Cardiovascular Intelligence Zone | The Lipidologist and Atherosclerosis Specialist's Perspective

Presenter

Michael H. Davidson, MD, FACC, FACP, FNLA

Michael H. Davidson, MD, FACC, FACP, FNLA

Clinical Professor

Clinical Professor
Director of Preventive Cardiology
The University of Chicago Hospitals and Clinic
Pritzker School of Medicine
Chicago, Illinois